Novavax Announces COVID-19 Vaccine Clinical Development Progress
The Pharma Data
NOVEMBER 30, 2020
NVX-CoV2373 contains purified protein antigen and can neither replicate, nor can it cause COVID-19. We caution investors not to place considerable reliance on forward-looking statements contained in this press release. For more information, visit www.novavax.com and connect with us on Twitter and LinkedIn.
Let's personalize your content